Primary Record
Ecteinascidin 770
Note: Only for scientific research or as raw materials for production.
- In stock
- 5,234 g
- Purity
- 98.5 %
- CAS
- 114899-80-8
Compound Identifiers & Properties
- CAS
- 114899-80-8
- PubChem CID
- 10952807
- SMILES
- CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)C#N)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O
- Canonical SMILES
- COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1C#N)N2C)OCO4
Names & Synonyms
- Ecteinascidin 770
- Ecteinascidin770
- Ecteinascidine 770
- Ecteinascidin 770
- 114899-80-8
- RefChem:136270
- CHEMBL448144
- orb1709800
- SCHEMBL9765335
- SCHEMBL29711393
- Et-770
- BGFXHQYUWCGGLL-QWIBJBKUSA-N
- AKOS040733065
- CS-6236
- CID10952807
- CID 10350233
- MS-31394
- HY-101191
- J1.523.792I
- F85510
- A950468
- [(1R,2R,3R,11S,12R,14R,26R)-12-cyano-5,6'-dihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline]-22-yl] acetate
- ((1R,2R,12R,14R,26R)-12-cyano-5,6'-dihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro(17,19,28-trioxa-24-thia-13,30-diazaheptacyclo(12.9.6.13,11.02,13.04,9.015,23.016,20)triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline)-22-yl) acetate
- ((1R,2R,3R,11S,12R,14R,26R)-12-cyano-5,6'-dihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro(17,19,28-trioxa-24-thia-13,30-diazaheptacyclo(12.9.6.13,11.02,13.04,9.015,23.016,20)triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline)-22-yl) acetate
- (1 inverted exclamation markaR,6R,6aR,7R,13S,14R,16R)-5-(Acetyloxy)-3 inverted exclamation marka,4 inverted exclamation marka,6,6a,7,13,14,16-octahydro-6 inverted exclamation marka,8-dihydroxy-7 inverted exclamation marka,9-dimethoxy-4,10,23-trimethyl-19-oxospiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1 inverted exclamation marka(2 inverted exclamation markaH)-isoquinoline]-14-carbonitrile
- (1'R,6R,6aR,7R,13S,14R,16R)-5-(Acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8-dihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxospiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinoline]-14-carbonitrile (ACI); Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2'H)-isoquinoline]-14-carbonitrile, 5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8-dihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-, [6R-(6a,6ass,7ss,13ss,14ss,16a,20R*)]- (ZCI); Ecteinascidin 770; Ecteinascidine 770; Et 770
- (1R,2R,3R,11S,12R,14R,26R)-12-cyano-5,6'-dihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triacontane-26,1'-isoquinoline]-4,6,8,15,20,22-hexaen-22-yl acetate
- (1R,5S,6R,7R,11R,14R,14aR)-6 ,25-Dihydroxy-7 ,24-dimethoxy-10-oxo-17,18-(methylenedioxy)-19,21,23-trimethyl-20-acetoxy-1,3 ,4,4 ,5,6,7,8,14,14a-decahydrospiro[1,5-epimino-2,3-[1,3]butadieno-7,14-[1,2]benzeno-10H-9-oxa-13-thia-6a-azacyclooctacyclodecene-11(12H),1 (2 H)-isoquinoline]-6alpha-carbonitrile
- (1R,5S,6R,7R,11R,14R,14aR)-6 ,25-Dihydroxy-7 ,24-dimethoxy-17,18-(methylenedioxy)-19,21,23-trimethyl-20-acetoxy-10-oxo-1,3 ,4,4 ,5,6,7,8,14,14a-decahydrospiro[1,5-epimino-2,3-[1,3]butadieno-7,14-[1,2]benzeno-10H-9-oxa-13-thia-6a-azacyclooctacyclodecene-11(12H),1 (2 H)-isoquinoline]-6-carbonitrile